Ignite Creation Date:
2024-05-06 @ 3:32 AM
Last Modification Date:
2024-10-26 @ 11:35 AM
Study NCT ID:
NCT02318901
Status:
TERMINATED
Last Update Posted:
2019-10-21
First Post:
2014-12-08
Brief Title:
Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer
Sponsor:
Western Regional Medical Center
Organization:
Western Regional Medical Center
Organization Data
Organization:
Western Regional Medical Center
Class:
OTHER
Study ID:
PembroMab
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Western Regional Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None